HomeCompareFSEP vs JNJ

FSEP vs JNJ: Dividend Comparison 2026

FSEP yields 3.97% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSEP wins by $5.9K in total portfolio value
10 years
FSEP
FSEP
● Live price
3.97%
Share price
$50.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$512.87
Full FSEP calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FSEP vs JNJ

📍 FSEP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSEPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSEP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSEP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSEP
Annual income on $10K today (after 15% tax)
$337.77/yr
After 10yr DRIP, annual income (after tax)
$435.94/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $267.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSEP + JNJ for your $10,000?

FSEP: 50%JNJ: 50%
100% JNJ50/50100% FSEP
Portfolio after 10yr
$23.0K
Annual income
$670.33/yr
Blended yield
2.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FSEP
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSEP buys
0
JNJ buys
0
No recent congressional trades found for FSEP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSEPJNJ
Forward yield3.97%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.9K$20.0K
Annual income after 10y$512.87$827.78
Total dividends collected$4.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FSEP vs JNJ ($10,000, DRIP)

YearFSEP PortfolioFSEP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,097$397.38$10,676$355.77+$421.00FSEP
2$12,286$412.14$11,407$389.39+$879.00FSEP
3$13,573$426.44$12,198$426.53+$1.4KFSEP
4$14,963$440.27$13,056$467.62+$1.9KFSEP
5$16,464$453.62$13,987$513.12+$2.5KFSEP
6$18,083$466.47$14,998$563.56+$3.1KFSEP
7$19,828$478.82$16,098$619.52+$3.7KFSEP
8$21,706$490.67$17,295$681.69+$4.4KFSEP
9$23,728$502.02$18,599$750.82+$5.1KFSEP
10$25,902$512.87$20,022$827.78+$5.9KFSEP

FSEP vs JNJ: Complete Analysis 2026

FSEPStock

The investment objective of the FT Vest U.S. Equity Buffer ETF - September (the "Fund") is to seek to provide investors with returns (before fees and expenses) that match the price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a predetermined upside cap of 14.00% while providing a buffer (before fees and expenses) against the first 10% of Underlying ETF losses, over the period from September 22, 2025 to September 18, 2026.

Full FSEP Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FSEP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSEP vs SCHDFSEP vs JEPIFSEP vs OFSEP vs KOFSEP vs MAINFSEP vs ABBVFSEP vs MRKFSEP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.